Graham, Camilla S.
Bisson, Brianna
Shore, Jessica
Pardy, Emily
Salisbury, Frank
Lancaster, Lisa
Kulkarni, Tejaswini
Funding for this research was provided by:
PureTech Health
Article History
Received: 9 March 2025
Accepted: 28 April 2025
First Online: 8 May 2025
Declarations
:
: Both the qualitative and quantitative protocols were submitted to the Institutional Review Board Western-Copernicus Group (Puyallup, WA; references 1–1669153-1 and 1–1719988-1), and this study was determined exempt under 45 CFR § 46.104(d)(2). The study was conducted in accordance with the principles of the Declaration of Helsinki (Ethical Principles for Medical Research Involving Human Subjects). A third party vendor described risks to participation and obtained consent to participate in the qualitative interviews. For the on-line survey, consent was also obtained prior to participation (Additional file Survey Questionnaire).
: Not applicable.
: C.G., E.P, B.B. and F.S are current or former employees of PureTech Health and L.L and T.K are consultants to PureTech Health.